Delivery Order SPE2DB22D2206-SPE2DB24FFV46
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract. The award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025, and no set-aside designation was utilized. Performance will occur at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of SCEMBLIX 40 mg tablets (quantity: 60 units). This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $26,519 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA, leveraging the company's extensive capabilities as a major pharmaceutical distributor to the federal healthcare system. The delivery location is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,956.33 to AmerisourceBergen Drug Corp for SCEMBLIX 40 MG tablets (60 count) with a firm fixed price contract type. This non-set-aside award was issued on January 6, 2026, with an ultimate completion date of January 28, 2026. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through July 24, 2025. It is not designated as a set-aside contract, indicating open competition....
- The Defense Logistics Agency awarded a $26,519 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) under a competitively awarded, non-set-aside contract. The delivery order, issued on September 22, 2025, carries an ultimate completion date of October 14, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement fulfilling...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET in quantities of 60s, with a firm fixed price of $13,259.50 and a completion date of June 6, 2025. The contract is not set aside and is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $26,519.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568461040 - SCEMBLIX 40 MG TABLET UU 60S, a prescription medication, with a completion date of June 27, 2025. The contract is not set-aside and was awarded on June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract has a ceiling value of $13,259.50 and is a firm fixed-price delivery order. The place of performance is Conshohocken, Pennsylvania. The contract is not set-aside and is open to full and open competition....
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFV46Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide SCEMBLIX 40 MG TABLET UU 60S pharmaceuticals. The $24,304.14 contract has a completion date of March 20, 2024 and was awarded on February 28, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 2/28/24 |